Literature DB >> 25633005

Risk factors for central line-associated bloodstream infections in the era of prevention bundles.

Devin Callister1, Pauline Limchaiyawat1, Samantha J Eells1, Loren G Miller1.   

Abstract

Little is known about central line-associated bloodstream infection risk factors in the bundle era. In our case-control investigation, we found that independent risk factors for central line-associated bloodstream infection at our center included the number of recent lab tests, catheter duration, and lack of hemodynamic monitoring as the insertion indication. Infect Control Hosp Epidemiol 2014;00(0): 1-3.

Mesh：

Year:  2015        PMID： 25633005     DOI： 10.1017/ice.2014.32

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  7 in total

1.  Central line-associated bloodstream infections at the multidisciplinary intensive care unit of Universitas Academic Hospital, Bloemfontein, South Africa.

Authors:  E Glover; A Abrahamson; J Adams; S R Poken; S-L Hainsworth; A Lamprecht; T Delport; T Keulder; T Olivier; S D Maasdorp
Journal:  Afr J Thorac Crit Care Med       Date:  2022-05-05

2.  Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.

Authors:  Vassiliki Pitiriga; John Bakalis; Elsa Kampos; Petros Kanellopoulos; George Saroglou; Athanasios Tsakris
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-15       Impact factor: 6.454

Review 3.  A proposal for a comprehensive approach to infections across the surgical pathway.

Authors:  Massimo Sartelli; Leonardo Pagani; Stefania Iannazzo; Maria Luisa Moro; Pierluigi Viale; Angelo Pan; Luca Ansaloni; Federico Coccolini; Marcello Mario D'Errico; Iris Agreiter; Giorgio Amadio Nespola; Francesco Barchiesi; Valeria Benigni; Raffaella Binazzi; Stefano Cappanera; Alessandro Chiodera; Valentina Cola; Daniela Corsi; Francesco Cortese; Massimo Crapis; Francesco Cristini; Alessandro D'Arpino; Belinda De Simone; Stefano Di Bella; Francesco Di Marzo; Abele Donati; Daniele Elisei; Massimo Fantoni; Anna Ferrari; Domitilla Foghetti; Daniela Francisci; Gianni Gattuso; Andrea Giacometti; Guido Cesare Gesuelli; Cristina Marmorale; Enrica Martini; Marcello Meledandri; Rita Murri; Daniela Padrini; Dalia Palmieri; Paola Pauri; Carla Rebagliati; Enrico Ricchizzi; Vittorio Sambri; Anna Maria Schimizzi; Walter Siquini; Loredana Scoccia; Giancarlo Scoppettuolo; Gabriele Sganga; Nadia Storti; Marcello Tavio; Giulio Toccafondi; Fabio Tumietto; Bruno Viaggi; Marco Vivarelli; Cristian Tranà; Melina Raso; Francesco Maria Labricciosa; Sameer Dhingra; Fausto Catena
Journal:  World J Emerg Surg       Date:  2020-02-18       Impact factor: 5.469

4.  Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.

Authors:  Niccolò Buetti; Stéphane Ruckly; Jean-Christophe Lucet; Lila Bouadma; Maité Garrouste-Orgeas; Carole Schwebel; Olivier Mimoz; Bertrand Souweine; Jean-François Timsit
Journal:  Crit Care       Date:  2020-12-14       Impact factor: 9.097

5.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

6.  Impact of two bundles on central catheter-related bloodstream infection in critically ill patients.

Authors:  Cristobal Felipe Padilla Fortunatti
Journal:  Rev Lat Am Enfermagem       Date:  2017-12-04

7.  Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital.

Authors:  Adam Frymoyer; Hayden T Schwenk; Yvonne Zorn; Laura Bio; Jeffrey D Moss; Bhavin Chasmawala; Joshua Faulkenberry; Srijib Goswami; Ron J Keizer; Shabnam Ghaskari
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.